Castiglione and Ingolia win Keck Foundation grants
Gianni Castiglione, with several colleagues at Vanderbilt University, and Nicholas Ingolia received at least $1 million from the W.M. Keck Foundation to fund their research. The foundation supports projects that are distinctive and novel in their approach, as well as high-risk with the potential for transformative impact.
Castiglione is an assistant professor of biological sciences, ophthalmology and visual sciences at VU and a member of Vanderbilt’s Evolutionary Studies Initiative. His lab explores new directions in aging research by collaborating with experts from a wide range of disciplines across the Vanderbilt campus. Castiglione’s grant will help further research in reverse engineering the life span of birds. He hopes to uncover biological mechanisms behind exceptional longevity that could one day help safely extend the lives of humans.
“We’re drawing on these different disciplines, and that’s promoted here, rather than trying to fit into a box,” he said in a VU press release.
Ingolia is a professor of molecular and cell biology at the University of California, Berkeley. His lab studies how cells control the translation and stability of messenger RNA in the cytosol, and how this regulation fulfills important biological functions. Ingolia’s grant will be used toward the study of systematic testing of sequence–function relationships in intrinsically disordered proteins.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
In memoriam: Richard Wolfenden
He was an enzymologist whose work helped spur the development of ACE inhibitor drugs and has been an ASBMB member since 1967.
Tansey named department chair
He has been a faculty member at Otterbein University since 2002.
In memoriam: Joel Habener
He discovered GLP-1, which helped pave the way for transformative diabetes and obesity therapies, and he was an ASBMB member for 25 years.
In memoriam: Walter A. Shaw
He is the namesake for the Walter A. Shaw Young Investigator Award in Lipid Research and founded Avanti Polar Lipids.
Dorn named assistant professor
She will open her lab at the University of Vermont in fall 2026, and her research will focus on catalysis, synthetic methodology and medicinal chemistry.
The data that did not fit
Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.